ClinicalTrials.Veeva
Menu

Find clinical trials for Adenocarcinoma in Birmingham, AL

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Pancreatic Cancer
Colorectal Cancer
Non-Small-Cell Lung Carcinoma
Stomach Cancer
Prostatic Cancer
Esophageal Cancer
Cancer

Adenocarcinoma trials near Birmingham, AL, USA:

ProAgio in Pancreatic Ductal Adenocarcinoma (PDAC)

nab-paclitaxel (G-nP) or gemcitabine, nab-paclitaxel (G-nP) and atezolizumab in previously untreated subjects with metastatic pancreatic ductal adenocarcinoma...

Enrolling
Pancreatic Ductal Adenocarcinoma (PDAC)
Drug: ProAgio Dose Levels (DL) 1,2,3,4
Drug: Gemcitabine, nab paclitaxel

Phase 1

ProDa BioTech

Birmingham, Alabama, United States

Zolbetuximab is being studied in people with cancer in and around the stomach or where the food pipe (esophagus) joins the stomach, called gastroesop...

Enrolling
Metastatic Gastric Adenocarcinoma or Cancer
Locally Advanced Unresectable Gastric Adenocarcinoma or Cancer
Drug: 5-fluorouracil (5-FU)
Drug: Capecitabine

Phase 3

Astellas
Astellas

Birmingham, Alabama, United States and 237 other locations

Locations recently updated

is to evaluate the efficacy and safety of standard chemotherapy with or without INCB161734 in participants with metastatic pancreatic ductal adenocarcinoma...

Enrolling
Solid Tumors
Drug: Investigator's choice of chemotherapy
Drug: Placebo

Phase 3

Incyte
Incyte

Birmingham, Alabama, United States and 214 other locations

Barrett's Esophagus (BE), with or without dysplasia, and esophageal adenocarcinoma (EAC) as compared to Esophagogastroduodenoscopy (EGD) plu...

Enrolling
Esophageal Adenocarcinoma
Barretts Esophagus With Dysplasia
Diagnostic Test: Esophagogastroduodenoscopy
Device: EsoGuard (lab assay)
Lucid Diagnostics

Birmingham, Alabama, United States and 37 other locations

The purpose of this multicentric, open label trial (NAPISTAR 1-01) is to evaluate the safety/tolerability, pharmacokinetics and preliminary efficacy...

Enrolling
Non-small Cell Lung Cancer
Ovarian Cancer
Drug: TUB-040

Phase 1, Phase 2

Tubulis

Birmingham, Alabama, United States and 14 other locations

≥ 18 years with locally advanced or metastatic pancreatic ductal adenocarcinoma (PDAC), non-small cell lung cancer (NSCLC), HR+/HER2- ductal...

Enrolling
Pancreatic Ductal Adenocarcinoma
HR+/HER2- Ductal and Lobular Breast Cancer
Drug: [68Ga]Ga-NNS309
Drug: [177Lu]Lu-NNS309

Phase 1

Novartis
Novartis

Birmingham, Alabama, United States and 29 other locations

Study to investigate the efficacy, safety and tolerability of systemic chemotherapy plus ponsegromab versus systemic chemotherapy plus placebo for th...

Enrolling
Metastatic Pancreatic Ductal Adenocarcinoma
Cachexia
Drug: placebo
Drug: ponsegromab

Phase 2, Phase 3

Pfizer
Pfizer

Birmingham, Alabama, United States and 153 other locations

This is a randomized, phase 1b study to assess the safety, tolerability, pharmacokinetics (PK), and efficacy of sovilnesib at different dose levels t...

Active, not recruiting
High Grade Serous Adenocarcinoma of Ovary
Primary Peritoneal Carcinoma
Drug: Sovilnesib

Phase 1

Volastra Therapeutics

Birmingham, Alabama, United States and 12 other locations

locally-advanced , or medically inoperable pancreatic adenocarcinoma will translate into a decreased toxicity. The study will evaluate GI to...

Enrolling
Pancreatic Cancer
Radiation: Daily Adaptive External Beam Radiation Therapy
Varian

Birmingham, Alabama, United States and 2 other locations

This clinical trial is studying advanced solid tumors. Solid tumors are cancers that start in a part of your body like your lungs or liver instead of...

Active, not recruiting
Pancreatic Adenocarcinoma
Endometrial
Drug: PF-08052666

Phase 1

Seagen, a wholly owned subsidiary of Pfizer

Birmingham, Alabama, United States and 21 other locations

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems